Forbes J M & CO LLP Edwards Lifesciences Corp Transaction History

Forbes J M & CO LLP

$1 Billion
Q1 2025

A detailed history of Forbes J M & CO LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Forbes J M & CO LLP holds 5,285 shares of EW stock, worth $396,956. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,285

Previous 5,610 5.79%

Holding current value

$396,956

Previous $415,000 7.71%

% of portfolio

0.04%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$67.95 - $76.19 $22,083 - $24,761	-325 Reduced 5.79%	5,285 $383,000
Q3 2024 Oct 24, 2024	BUY	$59.7 - $93.78 $19,402 - $30,478	325 Added 6.15%	5,610 $370,000
Q3 2023 Nov 02, 2023	SELL	$69.28 - $93.38 $5,196 - $7,003	-75 Reduced 1.4%	5,285 $366,000
Q2 2023 Aug 03, 2023	BUY	$81.41 - $94.33 $6,105 - $7,074	75 Added 1.42%	5,360 $506,000
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $392,464 - $446,635	5,285 New	5,285 $437,000
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $366,088 - $468,678	5,360 New	5,360 $399,000
Q3 2021 Nov 05, 2021	SELL	$102.91 - $122.75 $84,694 - $101,023	-823 Reduced 13.47%	5,285 $598,000
Q2 2021 Aug 03, 2021	SELL	$83.84 - $104.76 $38,734 - $48,399	-462 Reduced 7.03%	6,108 $633,000
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $378,037 - $505,561	6,570 New	6,570 $454,000
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $114,777 - $177,390	-2,190 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$45.7 - $58.03 $2,742 - $3,481	-60 Reduced 2.67%	2,190 $381,000
Q2 2018 Aug 10, 2018	SELL	$42.45 - $51.3 $10,188 - $12,312	-240 Reduced 9.64%	2,250 $328,000
Q2 2017 Aug 10, 2017	BUY	N/A	2,490	2,490 $294,000

Others Institutions Holding EW

# of Institutions

1,374

Shares Held

453M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forbes J M & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Forbes J M & CO LLP with notifications on news.

Account